Cervical screening in Australia 2005-2006
Citation
AIHW
Department of Health and Ageing & AIHW (2008) Cervical screening in Australia 2005-2006, AIHW, Australian Government, accessed 19 April 2024.
APA
Department of Health and Ageing & AIHW . (2008). Cervical screening in Australia 2005-2006. Canberra: AIHW.
MLA
Department of Health and Ageing & AIHW . Cervical screening in Australia 2005-2006. AIHW, 2008.
Vancouver
Department of Health and Ageing & AIHW . Cervical screening in Australia 2005-2006. Canberra: AIHW; 2008.
Harvard
Department of Health and Ageing & AIHW 2008, Cervical screening in Australia 2005-2006, AIHW, Canberra.
PDF | 449Kb
The major objective of the National Cervical Screening Program is to reduce morbidity and mortality from cervical cancer by maximising early detection.Cervical screening in Australia 2005-2006 is the tenth annual report on key program activity, performance and outcome indicators to monitor the achievements of the National Cervical Screening Program. The report provides a comprehensive national picture of cervical screening in Australia for 2005-2006. The report presents the most recent information on participation in cervical screening, rate of early re-screening, low- and high-grade abnormalities detected, and incidence and mortality of cervical cancer. Where possible, data are presented by state and territory stratification as well as nationally.This report will be relevant to anyone with an interest in women's health or cervical screening, including health planners and administrators, various health practitioners, academic researchers and the general public.
- ISSN: 1039-3307
- ISBN: 978 1 74024 776 4
- Cat. no: CAN 36
- Pages: 136
-
In 2005–2006, there were 3,505,978 women who participated in the National Cervical Screening Program
-
In 2002–2006, there were 4,824,166 women who participated in the National Cervical Screening Program
-
Of women screened in February 2005 who had a normal Pap test result, 24.4% had a repeat Pap test within 21 months
-
In 2006, the screening program detected 29,532 abnormalities; 15,118 low-grade and 14,414 high-grade